Aubrey Hamilton

Adjuvant nivolumab following salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy: A single-arm phase II multi-institutional study.

V. Takiar, T. Wise-Draper, S. Wilson, 2021 .

Association of pathological response to neoadjuvant pembrolizumab with tumor PD-L1 expression and high disease-free survival (DFS) in patients with resectable, local-regionally advanced, head and neck squamous cell carcinoma (HNSCC).

V. Takiar, N. Dunlap, F. Worden, 2021, Journal of Clinical Oncology.